4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-005262
Options or other derivatives
- Chief Business Officer acquired 1,538,640 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 2020-01-16 | Grant or award · Option to purchase Ordinary Shares | +1,257,744 | 1,257,744 | D | ||
| TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 2020-01-16 | Grant or award · Option to purchase Ordinary Shares | +280,896 | 280,896 | D | ||
Loading xslF345X03/a4.xml…